by Gertrud U. Rey Almost sixty years have passed since the initial formalin-inactivated respiratory syncytial virus (RSV) vaccine caused enhanced disease in children when they were subsequently infected with the virus. Since then, RSV has continued to be a substantial public health threat to infants, young children, and older people. Although progress in developing a …
by Gertrud U. Rey Have you ever wondered what would happen if you were infected with two different viruses at the same time? A recent study aimed at addressing this question has produced some astounding new findings. The authors of the study wanted to observe the interactions between respiratory syncytial virus (RSV) and influenza A …
The mRNA vaccine platform is based on decades of previous studies, highlighting the importance of regularly funding basic research.
By Gertrud U. Rey Respiratory syncytial virus (RSV) is a leading cause of respiratory illness, including bronchiolitis and pneumonia, in the young, elderly, and immunocompromised. RSV poses a substantial public health threat due to its association with severe morbidity and mortality in infants and premature babies.
From the Washington Post: Dr. ROBERT M. CHANOCK (Age 86) On July 30, 2010 of Bethesda, MD. He was a resident in the Washington area for over 50 years, a distinguished scientist at the National Institute of Health. He received many awards and was a member of the National Academy of Sciences. He received his …
